Towards Healthcare
Non-Sterile Compounding Pharmacy Market Size Hits USD 6.41 Billion in 2025

Non-Sterile Compounding Pharmacy Market Surges with AI, HRT Demand & Veterinary Care

Market insights predict the global non-sterile compounding pharmacy industry will increase from USD 5.97 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 7.34%. The rise in OTC drug demand is driving the non-sterile compounding pharmacy market. North America dominates due to the strong presence of pharmaceutical key players. 

Content

  • Insight Code: 5864
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The non-sterile compounding pharmacy market is projected to reach USD 12.11 billion by 2034, growing at a CAGR of 7.34% from 2024 to 2034.

North America is currently leading the non-sterile compounding pharmacy market due to rising demand for pharmaceutical products in remote areas.

The non-sterile compounding pharmacy market includes six segments such as by dosage form, by therapeutic area, by type of compounding, by sales channel, by regulatory classification, and by region.

Some key players include Advanced Pharmacy, Avella Specialty Pharmacy, BCP (Belmar Pharma Solutions), CareFirst Specialty Pharmacy, Central Compounding Center, etc.

Key trends include rising demand for OTC products and rising prevalence of infectious and chronic conditions.

The compounding room or facility should have proper humidity and temperature control. It is important to have clean, flat surfaces and well-lit workplaces. Smoothness, imperviousness, lack of cracks and fissures (ideally seamless), and nonshedding are all desirable qualities for the work surface.

Several organizations and regulatory authorities supervise both sterile and non-sterile compounding procedures in pharmacies. These regulatory bodies and organizations include the FDA (Food and Drug Administration) and the U.S. Pharmacopeia (USP).  The FDA governs the food and pharmaceutical sectors.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions